BPGM and myocardial disorder: Consequently, this might contribute to the higher 28-day mortality rate in septic myocardial disease [7], which could denote a distinct aspect of glycolytic pathway alteration compared to sepsis alone, suggesting BPGM as a potential diagnostic or therapeutic target for septic myocardial disease.